Literature DB >> 16970601

Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.

Y Itsui1, N Sakamoto, M Kurosaki, N Kanazawa, Y Tanabe, T Koyama, Y Takeda, M Nakagawa, S Kakinuma, Y Sekine, S Maekawa, N Enomoto, M Watanabe.   

Abstract

Type-I interferons (IFNs) and the interferon-stimulated genes (ISGs) play a major role in antivirus responses against hepatitis C virus (HCV) infection. In this study, we studied expression profiles of ISGs in cells supporting subgenomic HCV replication (Huh7/Rep), and screened their activities to suppress HCV replication. Real-time PCR analyses showed that the expression levels of 23 ISGs were significantly lower in Huh7/Rep than naive Huh7 cells due to transcriptional suppression of the interferon-stimulated response element (ISRE). Furthermore, the expression level of ISGs was also decreased in the cured Huh7 cells in which replicon had been eliminated (cHuh7), indicating adaptation of the cells to support HCV replication by downregulating ISGs. On the other hand, expression of HCV replicon was significantly suppressed by overexpression of several ISGs including PKR, MxA, IRF-9, GBP-1, IFI-6-16, IFI-27, 25OAS and IRF-1. Knock down of GBP-1, IFI-6-16 and IFI-27 by short hairpin RNA resulted in increase of HCV replication. Thus, we conclude that downregulation of ISG expression is required in the host cells supporting HCV replication and that several ISGs directly suppress HCV replication. The search for ISGs that regulate HCV replication may help to elucidate the cellular antiviral defence mechanisms against HCV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16970601     DOI: 10.1111/j.1365-2893.2006.00732.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  62 in total

1.  Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91.

Authors:  Yusuke Funaoka; Naoya Sakamoto; Goki Suda; Yasuhiro Itsui; Mina Nakagawa; Sei Kakinuma; Takako Watanabe; Kako Mishima; Mayumi Ueyama; Izumi Onozuka; Sayuri Nitta; Akiko Kitazume; Kei Kiyohashi; Miyako Murakawa; Seishin Azuma; Kiichiro Tsuchiya; Mamoru Watanabe
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

Review 2.  Regulation of hepatic innate immunity by hepatitis C virus.

Authors:  Stacy M Horner; Michael Gale
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

3.  Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.

Authors:  Hangfei Qi; Virginia Chu; Nicholas C Wu; Zugen Chen; Shawna Truong; Gurpreet Brar; Sheng-Yao Su; Yushen Du; Vaithilingaraja Arumugaswami; C Anders Olson; Shu-Hua Chen; Chung-Yen Lin; Ting-Ting Wu; Ren Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-03       Impact factor: 11.205

4.  Effect of P-body component Mov10 on HCV virus production and infectivity.

Authors:  Dandan Liu; Tanyaradzwa P Ndongwe; Maritza Puray-Chavez; Mary C Casey; Taisuke Izumi; Vinay K Pathak; Philip R Tedbury; Stefan G Sarafianos
Journal:  FASEB J       Date:  2020-06-04       Impact factor: 5.191

5.  Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis.

Authors:  M Schnoor; A Betanzos; D A Weber; C A Parkos
Journal:  Mucosal Immunol       Date:  2008-09-17       Impact factor: 7.313

Review 6.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

7.  Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells.

Authors:  Yuki Nishimura-Sakurai; Naoya Sakamoto; Kaoru Mogushi; Satoshi Nagaie; Mina Nakagawa; Yasuhiro Itsui; Megumi Tasaka-Fujita; Yuko Onuki-Karakama; Goki Suda; Kako Mishima; Machi Yamamoto; Mayumi Ueyama; Yusuke Funaoka; Takako Watanabe; Seishin Azuma; Yuko Sekine-Osajima; Sei Kakinuma; Kiichiro Tsuchiya; Nobuyuki Enomoto; Hiroshi Tanaka; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2009-12-12       Impact factor: 7.527

8.  IL28B genotype and the expression of ISGs in normal liver.

Authors:  Zoe Raglow; Carly Thoma-Perry; Richard Gilroy; Yu-Jui Y Wan
Journal:  Liver Int       Date:  2013-03-24       Impact factor: 5.828

9.  The interferon-gamma-induced murine guanylate-binding protein-2 inhibits rac activation during cell spreading on fibronectin and after platelet-derived growth factor treatment: role for phosphatidylinositol 3-kinase.

Authors:  Angela F Messmer-Blust; Sujata Balasubramanian; Victoria Y Gorbacheva; Jonathan A Jeyaratnam; Deborah J Vestal
Journal:  Mol Biol Cell       Date:  2010-05-26       Impact factor: 4.138

10.  A functional genomic screen identifies cellular cofactors of hepatitis C virus replication.

Authors:  Andrew W Tai; Yair Benita; Lee F Peng; Sun-Suk Kim; Naoya Sakamoto; Ramnik J Xavier; Raymond T Chung
Journal:  Cell Host Microbe       Date:  2009-03-19       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.